Sage Therapeutics Inc (NAS:SAGE)
$ 11.09 0.46 (4.31%) Market Cap: 667.42 Mil Enterprise Value: -72.17 Mil PE Ratio: 0 PB Ratio: 0.95 GF Score: 46/100

SAGE Therapeutics Inc at Morgan Stanley Healthcare Conference Transcript

Sep 11, 2019 / 03:05PM GMT
Release Date Price: $159.37 (+5.01%)
Matthew Kelsey Harrison
Morgan Stanley, Research Division - Executive Director

So thanks for joining us for the next session. I'm Matthew Harrison, I'm one of the Biotech analysts here at Morgan Stanley. Just quickly before we get going, I need to read a disclosure statement.

Please note that all important disclosures, including personal holdings disclosures and Morgan Stanley disclosures, if you are on the Morgan Stanley public website at morganstanley.com/researchdisclosures, or you can pick up your own copy at the registration desk.

So I'm very pleased to have Sage with us for our next presentation. Kimi, I think you want to make some opening comments, which we'll let you do, and then we can jump right into it.

Kimi E. Iguchi
Sage Therapeutics, Inc. - CFO & Treasurer

Great. Thank you. So I'm Kimi Iguchi. I'm the CFO at Sage. And like Matthew, I have to start with my housekeeping, we will be making forward-looking statements.

So feel free to check out our SEC filings on our website. But what I'm really here to talk about is

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot